Life Sciences Legal Strategy
Patlytics is speaking about how faster, citation-backed patent analysis fits into life science legal teams' IP strategy.
Meet With Patlytics
Schedule a time or stop by Booth #10 to discuss how Patlytics can help your team.
“AI Legal Tools in the Life Sciences: From Experimentation to Integration”
Andy Riley, Senior Legal Engineer & IP Counsel
A roundtable discussion on how life science legal teams are moving AI tools from early experimentation into everyday practice.
Patlytics will be available at LSLS to talk with pharma and biotech legal teams about where patent litigation and prosecution intersect with regulatory and corporate decisions. Listen in on our roundtable or book a meeting to discuss AI in IP and how Patlytics supports life science teams.
Moving AI from experimentation to integration
Most life science legal teams have tested AI, the harder step is making it part of daily practice. Our roundtable digs into what that transition actually looks like.
FTO before launch
Search and analysis across US, EP, KR, JP, WO, TW, and CN filings, backed by a 130M+ patent database and 300M+ NPL works.
Meet us at Booth #10
Bring your questions about Patlytics to Booth #10 and we will walk through them live.
Will you be at LSLS?
Schedule a time to meet during the event.
Andrew Riley leads the life sciences and chemicals effort on the strategy team. He came to Patlytics from in-house roles at Siemens Healthiners and a cancer diagnostics startup, and before that spent more than a decade in the IP Litigation group at Goodwin, counseling pharmaceutical clients on litigation and prosecution matters. Dr. Riley holds a JD from Fordham University School of Law and a PhD in chemistry from UCLA.
Nate Kamer is an enterprise technology sales professional with a background spanning datacenter infrastructure, hybrid cloud platforms, and AI, previously at Dell Technologies and Nutanix. At Patlytics, he works with law firms and corporations to implement AI for time and cost savings and to strengthen the quality of their IP work.